XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Business Segment and Geographical Information (Tables)
 6 Months Ended
Jul. 02, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block] Business Segment Information
Three months endedSix months ended
July 2,July 3,July 2,July 3,
(In millions)2022202120222021
Revenues
Life Sciences Solutions
$3,292 $3,557 $7,523 $7,760 
Analytical Instruments
1,607 1,481 3,125 2,868 
Specialty Diagnostics
1,101 1,235 2,583 2,850 
Laboratory Products and Biopharma Services
5,537 3,583 10,979 7,180 
Eliminations
(567)(583)(1,422)(1,479)
Consolidated revenues
10,970 9,273 22,788 19,179 
Segment Income
Life Sciences Solutions
1,327 1,718 3,503 3,997 
Analytical Instruments
344 280 645 552 
Specialty Diagnostics
243 245 596 673 
Laboratory Products and Biopharma Services
691 446 1,311 977 
Subtotal reportable segments
2,605 2,689 6,055 6,199 
Cost of revenues adjustments
(8)— (19)(8)
Selling, general and administrative expenses adjustments
28 42 21 26 
Restructuring and other costs
(24)(119)(26)(133)
Amortization of acquisition-related intangible assets
(600)(449)(1,209)(872)
Consolidated operating income
2,001 2,163 4,822 5,212 
Interest income 36 11 54 23 
Interest expense(148)(122)(284)(247)
Other income/(expense)
28 (3)(135)(186)
Income before income taxes
$1,917 $2,049 $4,457 $4,802 
Cost of revenues adjustments included in the above table consist of charges for the sale of inventories revalued at the date of acquisition. Selling, general and administrative expenses adjustments included in the above table consist of third-party transaction/integration costs related to recent acquisitions, and charges/credits for changes in estimates of contingent acquisition consideration.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Business Segment Information
Three months endedSix months ended
July 2,July 3,July 2,July 3,
(In millions)2022202120222021
Revenues
Life Sciences Solutions
$3,292 $3,557 $7,523 $7,760 
Analytical Instruments
1,607 1,481 3,125 2,868 
Specialty Diagnostics
1,101 1,235 2,583 2,850 
Laboratory Products and Biopharma Services
5,537 3,583 10,979 7,180 
Eliminations
(567)(583)(1,422)(1,479)
Consolidated revenues
10,970 9,273 22,788 19,179 
Segment Income
Life Sciences Solutions
1,327 1,718 3,503 3,997 
Analytical Instruments
344 280 645 552 
Specialty Diagnostics
243 245 596 673 
Laboratory Products and Biopharma Services
691 446 1,311 977 
Subtotal reportable segments
2,605 2,689 6,055 6,199 
Cost of revenues adjustments
(8)— (19)(8)
Selling, general and administrative expenses adjustments
28 42 21 26 
Restructuring and other costs
(24)(119)(26)(133)
Amortization of acquisition-related intangible assets
(600)(449)(1,209)(872)
Consolidated operating income
2,001 2,163 4,822 5,212 
Interest income 36 11 54 23 
Interest expense(148)(122)(284)(247)
Other income/(expense)
28 (3)(135)(186)
Income before income taxes
$1,917 $2,049 $4,457 $4,802 
Cost of revenues adjustments included in the above table consist of charges for the sale of inventories revalued at the date of acquisition. Selling, general and administrative expenses adjustments included in the above table consist of third-party transaction/integration costs related to recent acquisitions, and charges/credits for changes in estimates of contingent acquisition consideration.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Three months endedSix months ended
July 2,July 3,July 2,July 3,
(In millions)2022202120222021
Revenues
United States
$5,846 $4,355 $11,943 $9,247 
China
1,001 794 1,911 1,569 
Other
4,123 4,124 8,934 8,363 
Consolidated revenues
$10,970 $9,273 $22,788 $19,179